?>
Logo

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 401k Plan overview

Plan NamePHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN
Plan identification number 002

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN Benefits

401k Plan TypeDefined Contribution Pension
Plan Features/Benefits
  • Profit-sharing
  • ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
  • Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
  • Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
  • Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
  • Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
  • Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.

401k Sponsoring company profile

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA has sponsored the creation of one or more 401k plans.

Company Name:PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Employer identification number (EIN):530241211
NAIC Classification:541700

Additional information about PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Jurisdiction of Incorporation: State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number: 521924

More information about PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Form 5500 Filing Information

Submission information for form 5500 for 401k plan PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator SignedName of Company SponsorDate Sponsor Signed
0022022-01-01
0022021-01-01
0022020-01-01
0022019-01-01
0022018-01-01
0022017-01-01PAUL AINES
0022016-01-01PAUL A. AINES
0022015-01-01PAUL AINES
0022014-01-01NAOMI MORALES PAUL AINES2015-09-22
0022013-01-01DEL PERSINGER NAOMI M MORALES2014-10-06
0022012-01-01DEL PERSINGER NAOMI MORALES2013-10-15
0022011-01-01DEL PERSINGER NAOMI MORALES2012-10-11
0022009-01-01TRACEY MERCHANT DEL PERSINGER2010-10-08

Plan Statistics for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN

401k plan membership statisitcs for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN

Measure Date Value
2022: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2022 401k membership
Total participants, beginning-of-year2022-01-01373
Total number of active participants reported on line 7a of the Form 55002022-01-01243
Number of retired or separated participants receiving benefits2022-01-013
Number of other retired or separated participants entitled to future benefits2022-01-01137
Total of all active and inactive participants2022-01-01383
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2022-01-010
Total participants2022-01-01383
Number of participants with account balances2022-01-01383
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2022-01-010
2021: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2021 401k membership
Total participants, beginning-of-year2021-01-01356
Total number of active participants reported on line 7a of the Form 55002021-01-01239
Number of retired or separated participants receiving benefits2021-01-012
Number of other retired or separated participants entitled to future benefits2021-01-01132
Total of all active and inactive participants2021-01-01373
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2021-01-010
Total participants2021-01-01373
Number of participants with account balances2021-01-01373
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2021-01-010
2020: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2020 401k membership
Total participants, beginning-of-year2020-01-01346
Total number of active participants reported on line 7a of the Form 55002020-01-01232
Number of retired or separated participants receiving benefits2020-01-012
Number of other retired or separated participants entitled to future benefits2020-01-01122
Total of all active and inactive participants2020-01-01356
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2020-01-010
Total participants2020-01-01356
Number of participants with account balances2020-01-01356
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2020-01-010
2019: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2019 401k membership
Total participants, beginning-of-year2019-01-01332
Total number of active participants reported on line 7a of the Form 55002019-01-01226
Number of retired or separated participants receiving benefits2019-01-010
Number of other retired or separated participants entitled to future benefits2019-01-01120
Total of all active and inactive participants2019-01-01346
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2019-01-010
Total participants2019-01-01346
Number of participants with account balances2019-01-01346
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2019-01-010
2018: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2018 401k membership
Total participants, beginning-of-year2018-01-01324
Total number of active participants reported on line 7a of the Form 55002018-01-01215
Number of retired or separated participants receiving benefits2018-01-010
Number of other retired or separated participants entitled to future benefits2018-01-01117
Total of all active and inactive participants2018-01-01332
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2018-01-010
Total participants2018-01-01332
Number of participants with account balances2018-01-01332
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2018-01-010
2017: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2017 401k membership
Total participants, beginning-of-year2017-01-01297
Total number of active participants reported on line 7a of the Form 55002017-01-01207
Number of retired or separated participants receiving benefits2017-01-010
Number of other retired or separated participants entitled to future benefits2017-01-01117
Total of all active and inactive participants2017-01-01324
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2017-01-010
Total participants2017-01-01324
Number of participants with account balances2017-01-01324
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2017-01-010
2016: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2016 401k membership
Total participants, beginning-of-year2016-01-01286
Total number of active participants reported on line 7a of the Form 55002016-01-01183
Number of retired or separated participants receiving benefits2016-01-010
Number of other retired or separated participants entitled to future benefits2016-01-01114
Total of all active and inactive participants2016-01-01297
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2016-01-010
Total participants2016-01-01297
Number of participants with account balances2016-01-01297
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2016-01-011
2015: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2015 401k membership
Total participants, beginning-of-year2015-01-01303
Total number of active participants reported on line 7a of the Form 55002015-01-01183
Number of retired or separated participants receiving benefits2015-01-010
Number of other retired or separated participants entitled to future benefits2015-01-01103
Total of all active and inactive participants2015-01-01286
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2015-01-010
Total participants2015-01-01286
Number of participants with account balances2015-01-01286
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2015-01-010
2014: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2014 401k membership
Total participants, beginning-of-year2014-01-01271
Total number of active participants reported on line 7a of the Form 55002014-01-01200
Number of retired or separated participants receiving benefits2014-01-010
Number of other retired or separated participants entitled to future benefits2014-01-01103
Total of all active and inactive participants2014-01-01303
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2014-01-010
Total participants2014-01-01303
Number of participants with account balances2014-01-01281
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2014-01-010
2013: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2013 401k membership
Total participants, beginning-of-year2013-01-01273
Total number of active participants reported on line 7a of the Form 55002013-01-01176
Number of retired or separated participants receiving benefits2013-01-0195
Number of other retired or separated participants entitled to future benefits2013-01-010
Total of all active and inactive participants2013-01-01271
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2013-01-010
Total participants2013-01-01271
Number of participants with account balances2013-01-01257
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2013-01-010
2012: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2012 401k membership
Total participants, beginning-of-year2012-01-01273
Total number of active participants reported on line 7a of the Form 55002012-01-01173
Number of retired or separated participants receiving benefits2012-01-010
Number of other retired or separated participants entitled to future benefits2012-01-01100
Total of all active and inactive participants2012-01-01273
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2012-01-010
Total participants2012-01-01273
Number of participants with account balances2012-01-01257
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2012-01-010
2011: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2011 401k membership
Total participants, beginning-of-year2011-01-01276
Total number of active participants reported on line 7a of the Form 55002011-01-01174
Number of retired or separated participants receiving benefits2011-01-010
Number of other retired or separated participants entitled to future benefits2011-01-0197
Total of all active and inactive participants2011-01-01271
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2011-01-010
Total participants2011-01-01271
Number of participants with account balances2011-01-01250
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2011-01-010
2009: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2009 401k membership
Total participants, beginning-of-year2009-01-01259
Total number of active participants reported on line 7a of the Form 55002009-01-01200
Number of retired or separated participants receiving benefits2009-01-010
Number of other retired or separated participants entitled to future benefits2009-01-0181
Total of all active and inactive participants2009-01-01281
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits2009-01-010
Total participants2009-01-01281
Number of participants with account balances2009-01-01255
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested2009-01-011

Financial Data on PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN

Measure Date Value
2022 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2022 401k financial data
Total unrealized appreciation/depreciation of assets2022-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2022-12-31$0
Total income from all sources (including contributions)2022-12-31$-2,828,898
Total loss/gain on sale of assets2022-12-31$2,368,166
Total of all expenses incurred2022-12-31$9,103,280
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2022-12-31$9,099,625
Total contributions o plan (from employers,participants, others, non cash contrinutions)2022-12-31$16,884,876
Value of total assets at end of year2022-12-31$95,096,938
Value of total assets at beginning of year2022-12-31$107,029,116
Total of administrative expenses incurred including professional, contract, advisory and management fees2022-12-31$3,655
Total interest from all sources2022-12-31$151,289
Total dividends received (eg from common stock, registered investment company shares)2022-12-31$1,003,841
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2022-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2022-12-31$1,003,841
Was this plan covered by a fidelity bond2022-12-31Yes
Value of fidelity bond cover2022-12-31$1,000,000
If this is an individual account plan, was there a blackout period2022-12-31No
Were there any nonexempt tranactions with any party-in-interest2022-12-31No
Contributions received from participants2022-12-31$3,790,977
Participant contributions at end of year2022-12-31$435,750
Participant contributions at beginning of year2022-12-31$578,462
Income. Received or receivable in cash from other sources (including rollovers)2022-12-31$7,948,838
Administrative expenses (other) incurred2022-12-31$3,655
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Value of net income/loss2022-12-31$-11,932,178
Value of net assets at end of year (total assets less liabilities)2022-12-31$95,096,938
Value of net assets at beginning of year (total assets less liabilities)2022-12-31$107,029,116
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2022-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2022-12-31No
Were any leases to which the plan was party in default or uncollectible2022-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2022-12-31$65,256,523
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2022-12-31$73,299,437
Value of interest in pooled separate accounts at end of year2022-12-31$19,329,837
Value of interest in pooled separate accounts at beginning of year2022-12-31$27,569,403
Interest on participant loans2022-12-31$23,427
Interest earned on other investments2022-12-31$127,862
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2022-12-31$10,074,828
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2022-12-31$5,581,814
Net investment gain/loss from registered investment companies (e.g. mutual funds)2022-12-31$-15,611,800
Net investment gain/loss from pooled separate accounts2022-12-31$-7,625,270
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2022-12-31No
Was there a failure to transmit to the plan any participant contributions2022-12-31No
Has the plan failed to provide any benefit when due under the plan2022-12-31No
Contributions received in cash from employer2022-12-31$5,145,061
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2022-12-31$9,099,625
Did the plan have assets held for investment2022-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2022-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2022-12-31No
Aggregate proceeds on sale of assets2022-12-31$2,368,166
Opinion of an independent qualified public accountant for this plan2022-12-31Unqualified
Accountancy firm name2022-12-31BDO USA, P.C
Accountancy firm EIN2022-12-31135381590
2021 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2021 401k financial data
Total unrealized appreciation/depreciation of assets2021-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2021-12-31$0
Total income from all sources (including contributions)2021-12-31$22,610,548
Total loss/gain on sale of assets2021-12-31$3,591,302
Total of all expenses incurred2021-12-31$4,439,449
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2021-12-31$4,439,214
Total contributions o plan (from employers,participants, others, non cash contrinutions)2021-12-31$9,468,026
Value of total assets at end of year2021-12-31$107,029,116
Value of total assets at beginning of year2021-12-31$88,858,017
Total of administrative expenses incurred including professional, contract, advisory and management fees2021-12-31$235
Total interest from all sources2021-12-31$115,801
Total dividends received (eg from common stock, registered investment company shares)2021-12-31$826,641
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2021-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2021-12-31$826,641
Was this plan covered by a fidelity bond2021-12-31Yes
Value of fidelity bond cover2021-12-31$1,000,000
If this is an individual account plan, was there a blackout period2021-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2021-12-31$0
Were there any nonexempt tranactions with any party-in-interest2021-12-31No
Contributions received from participants2021-12-31$3,669,409
Participant contributions at end of year2021-12-31$578,462
Participant contributions at beginning of year2021-12-31$453,179
Income. Received or receivable in cash from other sources (including rollovers)2021-12-31$940,196
Administrative expenses (other) incurred2021-12-31$235
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Value of net income/loss2021-12-31$18,171,099
Value of net assets at end of year (total assets less liabilities)2021-12-31$107,029,116
Value of net assets at beginning of year (total assets less liabilities)2021-12-31$88,858,017
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2021-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2021-12-31No
Were any leases to which the plan was party in default or uncollectible2021-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2021-12-31$73,299,437
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2021-12-31$60,456,785
Value of interest in pooled separate accounts at end of year2021-12-31$27,569,403
Value of interest in pooled separate accounts at beginning of year2021-12-31$22,272,326
Interest on participant loans2021-12-31$27,635
Interest earned on other investments2021-12-31$88,166
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2021-12-31$5,581,814
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2021-12-31$5,675,727
Net investment gain/loss from registered investment companies (e.g. mutual funds)2021-12-31$3,628,764
Net investment gain/loss from pooled separate accounts2021-12-31$4,980,014
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2021-12-31No
Was there a failure to transmit to the plan any participant contributions2021-12-31No
Has the plan failed to provide any benefit when due under the plan2021-12-31No
Contributions received in cash from employer2021-12-31$4,858,421
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2021-12-31$4,439,214
Did the plan have assets held for investment2021-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2021-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2021-12-31No
Aggregate proceeds on sale of assets2021-12-31$3,591,302
Opinion of an independent qualified public accountant for this plan2021-12-31Unqualified
Accountancy firm name2021-12-31BDO
Accountancy firm EIN2021-12-31135381590
2020 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2020 401k financial data
Total unrealized appreciation/depreciation of assets2020-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2020-12-31$0
Total income from all sources (including contributions)2020-12-31$21,226,462
Total loss/gain on sale of assets2020-12-31$592,367
Total of all expenses incurred2020-12-31$4,435,999
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2020-12-31$4,442,094
Total contributions o plan (from employers,participants, others, non cash contrinutions)2020-12-31$8,947,307
Value of total assets at end of year2020-12-31$88,858,017
Value of total assets at beginning of year2020-12-31$72,067,554
Total of administrative expenses incurred including professional, contract, advisory and management fees2020-12-31$-6,095
Total interest from all sources2020-12-31$127,650
Total dividends received (eg from common stock, registered investment company shares)2020-12-31$796,731
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2020-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2020-12-31$796,731
Was this plan covered by a fidelity bond2020-12-31Yes
Value of fidelity bond cover2020-12-31$1,000,000
If this is an individual account plan, was there a blackout period2020-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2020-12-31$0
Were there any nonexempt tranactions with any party-in-interest2020-12-31No
Contributions received from participants2020-12-31$3,394,290
Participant contributions at end of year2020-12-31$453,179
Participant contributions at beginning of year2020-12-31$387,614
Income. Received or receivable in cash from other sources (including rollovers)2020-12-31$954,859
Administrative expenses (other) incurred2020-12-31$-6,095
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Value of net income/loss2020-12-31$16,790,463
Value of net assets at end of year (total assets less liabilities)2020-12-31$88,858,017
Value of net assets at beginning of year (total assets less liabilities)2020-12-31$72,067,554
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2020-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2020-12-31No
Were any leases to which the plan was party in default or uncollectible2020-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2020-12-31$60,456,785
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2020-12-31$49,294,571
Value of interest in pooled separate accounts at end of year2020-12-31$22,272,326
Value of interest in pooled separate accounts at beginning of year2020-12-31$17,315,115
Interest on participant loans2020-12-31$21,554
Interest earned on other investments2020-12-31$106,096
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2020-12-31$5,675,727
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2020-12-31$5,070,254
Net investment gain/loss from registered investment companies (e.g. mutual funds)2020-12-31$6,193,126
Net investment gain/loss from pooled separate accounts2020-12-31$4,569,281
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2020-12-31No
Was there a failure to transmit to the plan any participant contributions2020-12-31No
Has the plan failed to provide any benefit when due under the plan2020-12-31No
Contributions received in cash from employer2020-12-31$4,598,158
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2020-12-31$4,442,094
Did the plan have assets held for investment2020-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2020-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2020-12-31No
Aggregate proceeds on sale of assets2020-12-31$592,367
Opinion of an independent qualified public accountant for this plan2020-12-31Unqualified
Accountancy firm name2020-12-31BDO
Accountancy firm EIN2020-12-31135381590
2019 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2019 401k financial data
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total unrealized appreciation/depreciation of assets2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2019-12-31$0
Total income from all sources (including contributions)2019-12-31$22,416,436
Total loss/gain on sale of assets2019-12-31$557,598
Total of all expenses incurred2019-12-31$3,730,061
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2019-12-31$3,739,320
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$9,355,891
Total contributions o plan (from employers,participants, others, non cash contrinutions)2019-12-31$9,355,891
Value of total assets at end of year2019-12-31$72,067,554
Value of total assets at end of year2019-12-31$72,067,554
Value of total assets at beginning of year2019-12-31$53,381,179
Total of administrative expenses incurred including professional, contract, advisory and management fees2019-12-31$-9,259
Total interest from all sources2019-12-31$138,584
Total interest from all sources2019-12-31$138,584
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$971,286
Total dividends received (eg from common stock, registered investment company shares)2019-12-31$971,286
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2019-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$971,286
Total dividends received from registered investment company shares (eg mutual funds)2019-12-31$971,286
Was this plan covered by a fidelity bond2019-12-31Yes
Was this plan covered by a fidelity bond2019-12-31Yes
Value of fidelity bond cover2019-12-31$1,000,000
Value of fidelity bond cover2019-12-31$1,000,000
If this is an individual account plan, was there a blackout period2019-12-31No
If this is an individual account plan, was there a blackout period2019-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2019-12-31$0
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Were there any nonexempt tranactions with any party-in-interest2019-12-31No
Contributions received from participants2019-12-31$3,125,148
Participant contributions at end of year2019-12-31$387,614
Participant contributions at end of year2019-12-31$387,614
Participant contributions at beginning of year2019-12-31$432,495
Participant contributions at beginning of year2019-12-31$432,495
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$1,929,948
Income. Received or receivable in cash from other sources (including rollovers)2019-12-31$1,929,948
Administrative expenses (other) incurred2019-12-31$-9,259
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Value of net income/loss2019-12-31$18,686,375
Value of net assets at end of year (total assets less liabilities)2019-12-31$72,067,554
Value of net assets at end of year (total assets less liabilities)2019-12-31$72,067,554
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$53,381,179
Value of net assets at beginning of year (total assets less liabilities)2019-12-31$53,381,179
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2019-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Were any leases to which the plan was party in default or uncollectible2019-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$49,294,571
Value of interest in registered invesment companies (eg mutual funds) at end of year2019-12-31$49,294,571
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2019-12-31$35,083,606
Value of interest in pooled separate accounts at end of year2019-12-31$17,315,115
Value of interest in pooled separate accounts at end of year2019-12-31$17,315,115
Value of interest in pooled separate accounts at beginning of year2019-12-31$12,760,715
Value of interest in pooled separate accounts at beginning of year2019-12-31$12,760,715
Interest on participant loans2019-12-31$24,247
Interest on participant loans2019-12-31$24,247
Interest earned on other investments2019-12-31$114,337
Interest earned on other investments2019-12-31$114,337
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2019-12-31$5,070,254
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2019-12-31$5,104,363
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2019-12-31$5,104,363
Net investment gain/loss from registered investment companies (e.g. mutual funds)2019-12-31$7,370,676
Net investment gain/loss from pooled separate accounts2019-12-31$4,022,401
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2019-12-31No
Was there a failure to transmit to the plan any participant contributions2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Has the plan failed to provide any benefit when due under the plan2019-12-31No
Contributions received in cash from employer2019-12-31$4,300,795
Contributions received in cash from employer2019-12-31$4,300,795
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2019-12-31$3,739,320
Did the plan have assets held for investment2019-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2019-12-31No
Aggregate proceeds on sale of assets2019-12-31$557,598
Aggregate proceeds on sale of assets2019-12-31$557,598
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2019-12-31Yes
Opinion of an independent qualified public accountant for this plan2019-12-31Disclaimer
Accountancy firm name2019-12-31RSM US LLP
Accountancy firm name2019-12-31RSM US LLP
Accountancy firm EIN2019-12-31420714325
2018 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2018 401k financial data
Total unrealized appreciation/depreciation of assets2018-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2018-12-31$0
Total income from all sources (including contributions)2018-12-31$4,215,066
Total loss/gain on sale of assets2018-12-31$755,702
Total of all expenses incurred2018-12-31$3,369,384
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2018-12-31$3,367,443
Total contributions o plan (from employers,participants, others, non cash contrinutions)2018-12-31$7,450,418
Value of total assets at end of year2018-12-31$53,381,179
Value of total assets at beginning of year2018-12-31$52,535,497
Total of administrative expenses incurred including professional, contract, advisory and management fees2018-12-31$1,941
Total interest from all sources2018-12-31$119,444
Total dividends received (eg from common stock, registered investment company shares)2018-12-31$663,175
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2018-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2018-12-31$663,175
Was this plan covered by a fidelity bond2018-12-31Yes
Value of fidelity bond cover2018-12-31$1,000,000
If this is an individual account plan, was there a blackout period2018-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2018-12-31$0
Were there any nonexempt tranactions with any party-in-interest2018-12-31No
Contributions received from participants2018-12-31$2,943,387
Participant contributions at end of year2018-12-31$432,495
Participant contributions at beginning of year2018-12-31$465,096
Income. Received or receivable in cash from other sources (including rollovers)2018-12-31$454,851
Administrative expenses (other) incurred2018-12-31$1,941
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Value of net income/loss2018-12-31$845,682
Value of net assets at end of year (total assets less liabilities)2018-12-31$53,381,179
Value of net assets at beginning of year (total assets less liabilities)2018-12-31$52,535,497
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2018-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2018-12-31No
Were any leases to which the plan was party in default or uncollectible2018-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2018-12-31$35,083,606
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2018-12-31$32,295,877
Value of interest in pooled separate accounts at end of year2018-12-31$12,760,715
Value of interest in pooled separate accounts at beginning of year2018-12-31$15,068,930
Interest on participant loans2018-12-31$23,644
Interest earned on other investments2018-12-31$95,800
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2018-12-31$5,104,363
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2018-12-31$4,705,594
Net investment gain/loss from registered investment companies (e.g. mutual funds)2018-12-31$-4,381,602
Net investment gain/loss from pooled separate accounts2018-12-31$-392,071
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2018-12-31No
Was there a failure to transmit to the plan any participant contributions2018-12-31No
Has the plan failed to provide any benefit when due under the plan2018-12-31No
Contributions received in cash from employer2018-12-31$4,052,180
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2018-12-31$3,367,443
Did the plan have assets held for investment2018-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2018-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2018-12-31No
Aggregate proceeds on sale of assets2018-12-31$755,702
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2018-12-31No
Opinion of an independent qualified public accountant for this plan2018-12-31Unqualified
Accountancy firm name2018-12-31TATE & TRYON
Accountancy firm EIN2018-12-31521855942
2017 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2017 401k financial data
Total unrealized appreciation/depreciation of assets2017-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2017-12-31$0
Total income from all sources (including contributions)2017-12-31$14,526,350
Total loss/gain on sale of assets2017-12-31$661,678
Total of all expenses incurred2017-12-31$6,782,194
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2017-12-31$6,780,249
Total contributions o plan (from employers,participants, others, non cash contrinutions)2017-12-31$6,829,304
Value of total assets at end of year2017-12-31$52,535,497
Value of total assets at beginning of year2017-12-31$44,791,341
Total of administrative expenses incurred including professional, contract, advisory and management fees2017-12-31$1,945
Total interest from all sources2017-12-31$99,032
Total dividends received (eg from common stock, registered investment company shares)2017-12-31$550,121
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2017-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2017-12-31$550,121
Was this plan covered by a fidelity bond2017-12-31Yes
Value of fidelity bond cover2017-12-31$1,000,000
If this is an individual account plan, was there a blackout period2017-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2017-12-31$0
Were there any nonexempt tranactions with any party-in-interest2017-12-31No
Contributions received from participants2017-12-31$2,518,232
Participant contributions at end of year2017-12-31$465,096
Participant contributions at beginning of year2017-12-31$360,563
Income. Received or receivable in cash from other sources (including rollovers)2017-12-31$770,045
Administrative expenses (other) incurred2017-12-31$1,945
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Value of net income/loss2017-12-31$7,744,156
Value of net assets at end of year (total assets less liabilities)2017-12-31$52,535,497
Value of net assets at beginning of year (total assets less liabilities)2017-12-31$44,791,341
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2017-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2017-12-31No
Were any leases to which the plan was party in default or uncollectible2017-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2017-12-31$32,295,877
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2017-12-31$26,103,246
Value of interest in pooled separate accounts at end of year2017-12-31$15,068,930
Value of interest in pooled separate accounts at beginning of year2017-12-31$13,663,851
Interest on participant loans2017-12-31$17,472
Interest earned on other investments2017-12-31$81,560
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2017-12-31$4,705,594
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2017-12-31$4,663,681
Net investment gain/loss from registered investment companies (e.g. mutual funds)2017-12-31$3,222,373
Net investment gain/loss from pooled separate accounts2017-12-31$3,163,842
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2017-12-31No
Was there a failure to transmit to the plan any participant contributions2017-12-31Yes
Has the plan failed to provide any benefit when due under the plan2017-12-31No
Contributions received in cash from employer2017-12-31$3,541,027
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2017-12-31$6,780,249
Did the plan have assets held for investment2017-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2017-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2017-12-31No
Aggregate proceeds on sale of assets2017-12-31$661,678
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2017-12-31Yes
Opinion of an independent qualified public accountant for this plan2017-12-31Disclaimer
Accountancy firm name2017-12-31TATE & TRYON
Accountancy firm EIN2017-12-31521855942
2016 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets2016-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2016-12-31$0
Total income from all sources (including contributions)2016-12-31$9,044,194
Total loss/gain on sale of assets2016-12-31$321,358
Total of all expenses incurred2016-12-31$4,198,548
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2016-12-31$4,183,760
Total contributions o plan (from employers,participants, others, non cash contrinutions)2016-12-31$6,040,261
Value of total assets at end of year2016-12-31$44,791,341
Value of total assets at beginning of year2016-12-31$39,945,695
Total of administrative expenses incurred including professional, contract, advisory and management fees2016-12-31$14,788
Total interest from all sources2016-12-31$93,488
Total dividends received (eg from common stock, registered investment company shares)2016-12-31$404,508
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2016-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2016-12-31$404,508
Was this plan covered by a fidelity bond2016-12-31Yes
Value of fidelity bond cover2016-12-31$1,000,000
If this is an individual account plan, was there a blackout period2016-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2016-12-31$0
Were there any nonexempt tranactions with any party-in-interest2016-12-31No
Contributions received from participants2016-12-31$2,423,410
Participant contributions at end of year2016-12-31$360,563
Participant contributions at beginning of year2016-12-31$226,464
Income. Received or receivable in cash from other sources (including rollovers)2016-12-31$233,287
Administrative expenses (other) incurred2016-12-31$14,788
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Value of net income/loss2016-12-31$4,845,646
Value of net assets at end of year (total assets less liabilities)2016-12-31$44,791,341
Value of net assets at beginning of year (total assets less liabilities)2016-12-31$39,945,695
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2016-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2016-12-31No
Were any leases to which the plan was party in default or uncollectible2016-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2016-12-31$26,103,246
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2016-12-31$21,819,657
Value of interest in pooled separate accounts at end of year2016-12-31$13,663,851
Value of interest in pooled separate accounts at beginning of year2016-12-31$13,559,838
Interest on participant loans2016-12-31$12,611
Interest earned on other investments2016-12-31$80,877
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2016-12-31$4,663,681
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2016-12-31$4,339,736
Net investment gain/loss from registered investment companies (e.g. mutual funds)2016-12-31$1,319,635
Net investment gain/loss from pooled separate accounts2016-12-31$864,944
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2016-12-31No
Was there a failure to transmit to the plan any participant contributions2016-12-31Yes
Has the plan failed to provide any benefit when due under the plan2016-12-31No
Contributions received in cash from employer2016-12-31$3,383,564
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2016-12-31$4,183,760
Did the plan have assets held for investment2016-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2016-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2016-12-31No
Aggregate proceeds on sale of assets2016-12-31$321,358
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2016-12-31No
Opinion of an independent qualified public accountant for this plan2016-12-31Unqualified
Accountancy firm name2016-12-31TATE & TRYON
Accountancy firm EIN2016-12-31521855942
2015 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets2015-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2015-12-31$0
Total income from all sources (including contributions)2015-12-31$6,217,096
Total loss/gain on sale of assets2015-12-31$742,649
Total of all expenses incurred2015-12-31$3,720,673
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2015-12-31$3,715,248
Total contributions o plan (from employers,participants, others, non cash contrinutions)2015-12-31$6,095,722
Value of total assets at end of year2015-12-31$39,945,695
Value of total assets at beginning of year2015-12-31$37,449,272
Total of administrative expenses incurred including professional, contract, advisory and management fees2015-12-31$5,425
Total interest from all sources2015-12-31$86,903
Total dividends received (eg from common stock, registered investment company shares)2015-12-31$374,377
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2015-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2015-12-31$374,377
Was this plan covered by a fidelity bond2015-12-31Yes
Value of fidelity bond cover2015-12-31$1,000,000
If this is an individual account plan, was there a blackout period2015-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2015-12-31$0
Were there any nonexempt tranactions with any party-in-interest2015-12-31No
Contributions received from participants2015-12-31$2,229,971
Participant contributions at end of year2015-12-31$226,464
Participant contributions at beginning of year2015-12-31$220,145
Assets. Other investments not covered elsewhere at end of year2015-12-31$0
Assets. Other investments not covered elsewhere at beginning of year2015-12-31$4,947,540
Income. Received or receivable in cash from other sources (including rollovers)2015-12-31$612,737
Administrative expenses (other) incurred2015-12-31$5,425
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Value of net income/loss2015-12-31$2,496,423
Value of net assets at end of year (total assets less liabilities)2015-12-31$39,945,695
Value of net assets at beginning of year (total assets less liabilities)2015-12-31$37,449,272
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2015-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2015-12-31No
Were any leases to which the plan was party in default or uncollectible2015-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2015-12-31$21,819,657
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2015-12-31$19,300,623
Value of interest in pooled separate accounts at end of year2015-12-31$13,559,838
Value of interest in pooled separate accounts at beginning of year2015-12-31$12,980,964
Interest on participant loans2015-12-31$8,441
Interest earned on other investments2015-12-31$78,462
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2015-12-31$4,339,736
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2015-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2015-12-31$-1,188,035
Net investment gain/loss from pooled separate accounts2015-12-31$105,480
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2015-12-31No
Was there a failure to transmit to the plan any participant contributions2015-12-31No
Has the plan failed to provide any benefit when due under the plan2015-12-31No
Contributions received in cash from employer2015-12-31$3,253,014
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2015-12-31$3,715,248
Did the plan have assets held for investment2015-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2015-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2015-12-31No
Aggregate proceeds on sale of assets2015-12-31$742,649
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2015-12-31No
Opinion of an independent qualified public accountant for this plan2015-12-31Unqualified
Accountancy firm name2015-12-31TATE & TRYON
Accountancy firm EIN2015-12-31521855942
2014 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets2014-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2014-12-31$0
Total income from all sources (including contributions)2014-12-31$7,561,778
Total loss/gain on sale of assets2014-12-31$855,678
Total of all expenses incurred2014-12-31$2,895,191
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2014-12-31$2,890,831
Value of total corrective distributions2014-12-31$0
Total contributions o plan (from employers,participants, others, non cash contrinutions)2014-12-31$5,686,524
Value of total assets at end of year2014-12-31$37,449,272
Value of total assets at beginning of year2014-12-31$32,782,685
Total of administrative expenses incurred including professional, contract, advisory and management fees2014-12-31$4,360
Total interest from all sources2014-12-31$90,698
Total dividends received (eg from common stock, registered investment company shares)2014-12-31$270,698
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2014-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2014-12-31$270,698
Was this plan covered by a fidelity bond2014-12-31Yes
Value of fidelity bond cover2014-12-31$1,000,000
If this is an individual account plan, was there a blackout period2014-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2014-12-31$0
Were there any nonexempt tranactions with any party-in-interest2014-12-31No
Contributions received from participants2014-12-31$2,169,849
Participant contributions at end of year2014-12-31$220,145
Participant contributions at beginning of year2014-12-31$248,530
Assets. Other investments not covered elsewhere at end of year2014-12-31$4,947,540
Assets. Other investments not covered elsewhere at beginning of year2014-12-31$4,495,995
Income. Received or receivable in cash from other sources (including rollovers)2014-12-31$399,984
Other income not declared elsewhere2014-12-31$0
Administrative expenses (other) incurred2014-12-31$4,360
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Value of net income/loss2014-12-31$4,666,587
Value of net assets at end of year (total assets less liabilities)2014-12-31$37,449,272
Value of net assets at beginning of year (total assets less liabilities)2014-12-31$32,782,685
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2014-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2014-12-31No
Were any leases to which the plan was party in default or uncollectible2014-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2014-12-31$19,300,623
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2014-12-31$16,610,136
Value of interest in pooled separate accounts at end of year2014-12-31$12,980,964
Value of interest in pooled separate accounts at beginning of year2014-12-31$11,428,024
Interest on participant loans2014-12-31$10,114
Interest earned on other investments2014-12-31$80,584
Net investment gain/loss from registered investment companies (e.g. mutual funds)2014-12-31$-340,772
Net investment gain/loss from pooled separate accounts2014-12-31$998,952
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2014-12-31No
Was there a failure to transmit to the plan any participant contributions2014-12-31No
Has the plan failed to provide any benefit when due under the plan2014-12-31No
Contributions received in cash from employer2014-12-31$3,116,691
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2014-12-31$2,890,831
Did the plan have assets held for investment2014-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2014-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2014-12-31No
Aggregate proceeds on sale of assets2014-12-31$855,678
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2014-12-31No
Opinion of an independent qualified public accountant for this plan2014-12-31Unqualified
Accountancy firm name2014-12-31TATE & TRYON
Accountancy firm EIN2014-12-31521855942
2013 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets2013-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2013-12-31$0
Total income from all sources (including contributions)2013-12-31$9,020,833
Total loss/gain on sale of assets2013-12-31$454,907
Total of all expenses incurred2013-12-31$3,581,654
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2013-12-31$3,576,999
Total contributions o plan (from employers,participants, others, non cash contrinutions)2013-12-31$3,409,939
Value of total assets at end of year2013-12-31$32,782,685
Value of total assets at beginning of year2013-12-31$27,343,506
Total of administrative expenses incurred including professional, contract, advisory and management fees2013-12-31$4,655
Total interest from all sources2013-12-31$101,237
Total dividends received (eg from common stock, registered investment company shares)2013-12-31$193,839
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2013-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2013-12-31$193,839
Was this plan covered by a fidelity bond2013-12-31Yes
Value of fidelity bond cover2013-12-31$1,000,000
If this is an individual account plan, was there a blackout period2013-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2013-12-31$0
Were there any nonexempt tranactions with any party-in-interest2013-12-31No
Contributions received from participants2013-12-31$2,231,938
Participant contributions at end of year2013-12-31$248,530
Participant contributions at beginning of year2013-12-31$232,054
Assets. Other investments not covered elsewhere at end of year2013-12-31$4,495,995
Assets. Other investments not covered elsewhere at beginning of year2013-12-31$5,365,880
Income. Received or receivable in cash from other sources (including rollovers)2013-12-31$90,745
Administrative expenses (other) incurred2013-12-31$4,655
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Value of net income/loss2013-12-31$5,439,179
Value of net assets at end of year (total assets less liabilities)2013-12-31$32,782,685
Value of net assets at beginning of year (total assets less liabilities)2013-12-31$27,343,506
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2013-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2013-12-31No
Were any leases to which the plan was party in default or uncollectible2013-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2013-12-31$16,610,136
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2013-12-31$9,357,131
Value of interest in pooled separate accounts at end of year2013-12-31$11,428,024
Value of interest in pooled separate accounts at beginning of year2013-12-31$12,388,441
Interest on participant loans2013-12-31$9,819
Interest earned on other investments2013-12-31$91,418
Net investment gain/loss from registered investment companies (e.g. mutual funds)2013-12-31$1,590,886
Net investment gain/loss from pooled separate accounts2013-12-31$3,270,025
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2013-12-31No
Was there a failure to transmit to the plan any participant contributions2013-12-31No
Has the plan failed to provide any benefit when due under the plan2013-12-31No
Contributions received in cash from employer2013-12-31$1,087,256
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2013-12-31$3,576,999
Did the plan have assets held for investment2013-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2013-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2013-12-31No
Aggregate proceeds on sale of assets2013-12-31$454,907
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2013-12-31No
Opinion of an independent qualified public accountant for this plan2013-12-31Unqualified
Accountancy firm name2013-12-31TATE & TRYON
Accountancy firm EIN2013-12-31521855942
2012 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2012 401k financial data
Total unrealized appreciation/depreciation of assets2012-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2012-12-31$0
Total income from all sources (including contributions)2012-12-31$6,126,732
Total loss/gain on sale of assets2012-12-31$185,573
Total of all expenses incurred2012-12-31$1,946,064
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2012-12-31$1,941,903
Total contributions o plan (from employers,participants, others, non cash contrinutions)2012-12-31$3,190,826
Value of total assets at end of year2012-12-31$27,343,506
Value of total assets at beginning of year2012-12-31$23,162,838
Total of administrative expenses incurred including professional, contract, advisory and management fees2012-12-31$4,161
Total interest from all sources2012-12-31$126,417
Total dividends received (eg from common stock, registered investment company shares)2012-12-31$159,034
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2012-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2012-12-31$159,034
Was this plan covered by a fidelity bond2012-12-31Yes
Value of fidelity bond cover2012-12-31$1,000,000
If this is an individual account plan, was there a blackout period2012-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2012-12-31$0
Were there any nonexempt tranactions with any party-in-interest2012-12-31No
Contributions received from participants2012-12-31$2,141,879
Participant contributions at end of year2012-12-31$232,054
Participant contributions at beginning of year2012-12-31$198,144
Assets. Other investments not covered elsewhere at end of year2012-12-31$5,365,880
Assets. Other investments not covered elsewhere at beginning of year2012-12-31$4,649,641
Income. Received or receivable in cash from other sources (including rollovers)2012-12-31$17,161
Administrative expenses (other) incurred2012-12-31$4,161
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Value of net income/loss2012-12-31$4,180,668
Value of net assets at end of year (total assets less liabilities)2012-12-31$27,343,506
Value of net assets at beginning of year (total assets less liabilities)2012-12-31$23,162,838
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2012-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2012-12-31No
Were any leases to which the plan was party in default or uncollectible2012-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2012-12-31$9,357,131
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2012-12-31$7,687,618
Value of interest in pooled separate accounts at end of year2012-12-31$12,388,441
Value of interest in pooled separate accounts at beginning of year2012-12-31$10,627,435
Interest on participant loans2012-12-31$9,471
Interest earned on other investments2012-12-31$116,946
Net investment gain/loss from registered investment companies (e.g. mutual funds)2012-12-31$1,061,090
Net investment gain/loss from pooled separate accounts2012-12-31$1,403,792
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2012-12-31No
Was there a failure to transmit to the plan any participant contributions2012-12-31No
Has the plan failed to provide any benefit when due under the plan2012-12-31No
Contributions received in cash from employer2012-12-31$1,031,786
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2012-12-31$1,941,903
Did the plan have assets held for investment2012-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2012-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2012-12-31No
Aggregate proceeds on sale of assets2012-12-31$185,573
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2012-12-31No
Opinion of an independent qualified public accountant for this plan2012-12-31Unqualified
Accountancy firm name2012-12-31TATE & TRYON
Accountancy firm EIN2012-12-31521855942
2011 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2011 401k financial data
Total unrealized appreciation/depreciation of assets2011-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2011-12-31$0
Total income from all sources (including contributions)2011-12-31$2,609,840
Total loss/gain on sale of assets2011-12-31$123,657
Total of all expenses incurred2011-12-31$2,049,518
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2011-12-31$2,045,800
Total contributions o plan (from employers,participants, others, non cash contrinutions)2011-12-31$2,799,029
Value of total assets at end of year2011-12-31$23,162,838
Value of total assets at beginning of year2011-12-31$22,602,516
Total of administrative expenses incurred including professional, contract, advisory and management fees2011-12-31$3,718
Total interest from all sources2011-12-31$122,036
Total dividends received (eg from common stock, registered investment company shares)2011-12-31$105,050
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2011-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2011-12-31$105,050
Was this plan covered by a fidelity bond2011-12-31Yes
Value of fidelity bond cover2011-12-31$1,000,000
If this is an individual account plan, was there a blackout period2011-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2011-12-31$0
Were there any nonexempt tranactions with any party-in-interest2011-12-31No
Contributions received from participants2011-12-31$1,929,737
Participant contributions at end of year2011-12-31$198,144
Participant contributions at beginning of year2011-12-31$203,108
Assets. Other investments not covered elsewhere at end of year2011-12-31$4,649,641
Assets. Other investments not covered elsewhere at beginning of year2011-12-31$4,332,578
Income. Received or receivable in cash from other sources (including rollovers)2011-12-31$153,732
Administrative expenses (other) incurred2011-12-31$3,718
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Value of net income/loss2011-12-31$560,322
Value of net assets at end of year (total assets less liabilities)2011-12-31$23,162,838
Value of net assets at beginning of year (total assets less liabilities)2011-12-31$22,602,516
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2011-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2011-12-31No
Were any leases to which the plan was party in default or uncollectible2011-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2011-12-31$7,687,618
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2011-12-31$5,601,264
Value of interest in pooled separate accounts at end of year2011-12-31$10,627,435
Value of interest in pooled separate accounts at beginning of year2011-12-31$12,465,566
Interest on participant loans2011-12-31$8,251
Interest earned on other investments2011-12-31$113,785
Net investment gain/loss from registered investment companies (e.g. mutual funds)2011-12-31$-612,429
Net investment gain/loss from pooled separate accounts2011-12-31$72,497
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2011-12-31No
Was there a failure to transmit to the plan any participant contributions2011-12-31No
Has the plan failed to provide any benefit when due under the plan2011-12-31No
Contributions received in cash from employer2011-12-31$715,560
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2011-12-31$2,045,800
Did the plan have assets held for investment2011-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2011-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2011-12-31No
Aggregate proceeds on sale of assets2011-12-31$123,657
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2011-12-31No
Opinion of an independent qualified public accountant for this plan2011-12-31Unqualified
Accountancy firm name2011-12-31TATE & TRYON
Accountancy firm EIN2011-12-31521855942
2010 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2010 401k financial data
Total unrealized appreciation/depreciation of assets2010-12-31$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)2010-12-31$0
Total income from all sources (including contributions)2010-12-31$5,302,789
Total loss/gain on sale of assets2010-12-31$0
Total of all expenses incurred2010-12-31$1,377,279
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others2010-12-31$1,373,697
Total contributions o plan (from employers,participants, others, non cash contrinutions)2010-12-31$2,805,421
Value of total assets at end of year2010-12-31$22,602,516
Value of total assets at beginning of year2010-12-31$18,677,006
Total of administrative expenses incurred including professional, contract, advisory and management fees2010-12-31$3,582
Total interest from all sources2010-12-31$124,910
Total dividends received (eg from common stock, registered investment company shares)2010-12-31$68,906
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year2010-12-31No
Total dividends received from registered investment company shares (eg mutual funds)2010-12-31$68,906
Was this plan covered by a fidelity bond2010-12-31Yes
Value of fidelity bond cover2010-12-31$1,000,000
If this is an individual account plan, was there a blackout period2010-12-31No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2010-12-31$0
Were there any nonexempt tranactions with any party-in-interest2010-12-31No
Contributions received from participants2010-12-31$2,027,670
Participant contributions at end of year2010-12-31$203,108
Participant contributions at beginning of year2010-12-31$107,240
Assets. Other investments not covered elsewhere at end of year2010-12-31$4,332,578
Assets. Other investments not covered elsewhere at beginning of year2010-12-31$3,994,142
Income. Received or receivable in cash from other sources (including rollovers)2010-12-31$21,393
Administrative expenses (other) incurred2010-12-31$3,582
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Value of net income/loss2010-12-31$3,925,510
Value of net assets at end of year (total assets less liabilities)2010-12-31$22,602,516
Value of net assets at beginning of year (total assets less liabilities)2010-12-31$18,677,006
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)2010-12-31No
Were any loans by the plan or fixed income obligations due to the plan in default2010-12-31No
Were any leases to which the plan was party in default or uncollectible2010-12-31No
Value of interest in registered invesment companies (eg mutual funds) at end of year2010-12-31$5,601,264
Value of interest in registered invesment companies (eg mutual funds) at beginning of year2010-12-31$570,107
Value of interest in pooled separate accounts at end of year2010-12-31$12,465,566
Value of interest in pooled separate accounts at beginning of year2010-12-31$14,005,517
Interest on participant loans2010-12-31$7,716
Interest earned on other investments2010-12-31$117,194
Value of funds held in insurance company general accounts (unallocated contracts) at end of year2010-12-31$0
Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year2010-12-31$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)2010-12-31$465,409
Net investment gain/loss from pooled separate accounts2010-12-31$1,838,143
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets2010-12-31No
Was there a failure to transmit to the plan any participant contributions2010-12-31Yes
Has the plan failed to provide any benefit when due under the plan2010-12-31No
Contributions received in cash from employer2010-12-31$756,358
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers2010-12-31$1,373,697
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-32010-12-31No
Did the plan have assets held for investment2010-12-31Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser2010-12-31No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC2010-12-31No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)2010-12-31No
Opinion of an independent qualified public accountant for this plan2010-12-31Unqualified
Accountancy firm name2010-12-31TATE & TRYON
Accountancy firm EIN2010-12-31521855942
2009 : PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2009 401k financial data
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities2009-12-31$0

Form 5500 Responses for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN

2022: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2022 form 5500 responses
2022-01-01Type of plan entitySingle employer plan
2022-01-01Submission has been amendedNo
2022-01-01This submission is the final filingNo
2022-01-01This return/report is a short plan year return/report (less than 12 months)No
2022-01-01Plan is a collectively bargained planNo
2022-01-01Plan funding arrangement – InsuranceYes
2022-01-01Plan funding arrangement – TrustYes
2022-01-01Plan benefit arrangement – InsuranceYes
2022-01-01Plan benefit arrangement - TrustYes
2021: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2021 form 5500 responses
2021-01-01Type of plan entitySingle employer plan
2021-01-01Submission has been amendedNo
2021-01-01This submission is the final filingNo
2021-01-01This return/report is a short plan year return/report (less than 12 months)No
2021-01-01Plan is a collectively bargained planNo
2021-01-01Plan funding arrangement – InsuranceYes
2021-01-01Plan funding arrangement – TrustYes
2021-01-01Plan benefit arrangement – InsuranceYes
2021-01-01Plan benefit arrangement - TrustYes
2020: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2020 form 5500 responses
2020-01-01Type of plan entitySingle employer plan
2020-01-01Submission has been amendedNo
2020-01-01This submission is the final filingNo
2020-01-01This return/report is a short plan year return/report (less than 12 months)No
2020-01-01Plan is a collectively bargained planNo
2020-01-01Plan funding arrangement – InsuranceYes
2020-01-01Plan funding arrangement – TrustYes
2020-01-01Plan benefit arrangement – InsuranceYes
2020-01-01Plan benefit arrangement - TrustYes
2019: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2019 form 5500 responses
2019-01-01Type of plan entitySingle employer plan
2019-01-01Submission has been amendedNo
2019-01-01This submission is the final filingNo
2019-01-01This return/report is a short plan year return/report (less than 12 months)No
2019-01-01Plan is a collectively bargained planNo
2019-01-01Plan funding arrangement – InsuranceYes
2019-01-01Plan funding arrangement – TrustYes
2019-01-01Plan benefit arrangement – InsuranceYes
2019-01-01Plan benefit arrangement - TrustYes
2018: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2018 form 5500 responses
2018-01-01Type of plan entitySingle employer plan
2018-01-01Submission has been amendedNo
2018-01-01This submission is the final filingNo
2018-01-01This return/report is a short plan year return/report (less than 12 months)No
2018-01-01Plan is a collectively bargained planNo
2018-01-01Plan funding arrangement – InsuranceYes
2018-01-01Plan funding arrangement – TrustYes
2018-01-01Plan benefit arrangement – InsuranceYes
2018-01-01Plan benefit arrangement - TrustYes
2017: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2017 form 5500 responses
2017-01-01Type of plan entitySingle employer plan
2017-01-01Submission has been amendedNo
2017-01-01This submission is the final filingNo
2017-01-01This return/report is a short plan year return/report (less than 12 months)No
2017-01-01Plan is a collectively bargained planNo
2017-01-01Plan funding arrangement – InsuranceYes
2017-01-01Plan funding arrangement – TrustYes
2017-01-01Plan benefit arrangement – InsuranceYes
2017-01-01Plan benefit arrangement - TrustYes
2016: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2016 form 5500 responses
2016-01-01Type of plan entitySingle employer plan
2016-01-01Submission has been amendedNo
2016-01-01This submission is the final filingNo
2016-01-01This return/report is a short plan year return/report (less than 12 months)No
2016-01-01Plan is a collectively bargained planNo
2016-01-01Plan funding arrangement – InsuranceYes
2016-01-01Plan funding arrangement – TrustYes
2016-01-01Plan benefit arrangement – InsuranceYes
2016-01-01Plan benefit arrangement - TrustYes
2015: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2015 form 5500 responses
2015-01-01Type of plan entitySingle employer plan
2015-01-01Submission has been amendedNo
2015-01-01This submission is the final filingNo
2015-01-01This return/report is a short plan year return/report (less than 12 months)No
2015-01-01Plan is a collectively bargained planNo
2015-01-01Plan funding arrangement – InsuranceYes
2015-01-01Plan funding arrangement – TrustYes
2015-01-01Plan benefit arrangement – InsuranceYes
2015-01-01Plan benefit arrangement - TrustYes
2014: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2014 form 5500 responses
2014-01-01Type of plan entitySingle employer plan
2014-01-01Submission has been amendedNo
2014-01-01This submission is the final filingNo
2014-01-01This return/report is a short plan year return/report (less than 12 months)No
2014-01-01Plan is a collectively bargained planNo
2014-01-01Plan funding arrangement – InsuranceYes
2014-01-01Plan funding arrangement – TrustYes
2014-01-01Plan benefit arrangement – InsuranceYes
2014-01-01Plan benefit arrangement - TrustYes
2013: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2013 form 5500 responses
2013-01-01Type of plan entitySingle employer plan
2013-01-01Submission has been amendedNo
2013-01-01This submission is the final filingNo
2013-01-01This return/report is a short plan year return/report (less than 12 months)No
2013-01-01Plan is a collectively bargained planNo
2013-01-01Plan funding arrangement – InsuranceYes
2013-01-01Plan funding arrangement – TrustYes
2013-01-01Plan benefit arrangement – InsuranceYes
2013-01-01Plan benefit arrangement - TrustYes
2012: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2012 form 5500 responses
2012-01-01Type of plan entitySingle employer plan
2012-01-01Submission has been amendedNo
2012-01-01This submission is the final filingNo
2012-01-01This return/report is a short plan year return/report (less than 12 months)No
2012-01-01Plan is a collectively bargained planNo
2012-01-01Plan funding arrangement – InsuranceYes
2012-01-01Plan funding arrangement – TrustYes
2012-01-01Plan benefit arrangement – InsuranceYes
2012-01-01Plan benefit arrangement - TrustYes
2011: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2011 form 5500 responses
2011-01-01Type of plan entitySingle employer plan
2011-01-01Submission has been amendedNo
2011-01-01This submission is the final filingNo
2011-01-01This return/report is a short plan year return/report (less than 12 months)No
2011-01-01Plan is a collectively bargained planNo
2011-01-01Plan funding arrangement – InsuranceYes
2011-01-01Plan funding arrangement – TrustYes
2011-01-01Plan benefit arrangement – InsuranceYes
2011-01-01Plan benefit arrangement - TrustYes
2009: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA DEFERRED SAVINGS PLAN 2009 form 5500 responses
2009-01-01Type of plan entitySingle employer plan
2009-01-01Submission has been amendedNo
2009-01-01This submission is the final filingNo
2009-01-01This return/report is a short plan year return/report (less than 12 months)No
2009-01-01Plan is a collectively bargained planNo
2009-01-01Plan funding arrangement – InsuranceYes
2009-01-01Plan funding arrangement – TrustYes
2009-01-01Plan benefit arrangement – InsuranceYes
2009-01-01Plan benefit arrangement - TrustYes

Insurance Providers Used on plan

PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number036948
Policy instance 1
Insurance contract or identification number036948
Number of Individuals Covered383
Insurance policy start date2022-01-01
Insurance policy end date2022-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number036948
Policy instance 1
Insurance contract or identification number036948
Number of Individuals Covered373
Insurance policy start date2021-01-01
Insurance policy end date2021-12-31
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number036948
Policy instance 1
Insurance contract or identification number036948
Number of Individuals Covered356
Insurance policy start date2020-01-01
Insurance policy end date2020-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number036948
Policy instance 1
Insurance contract or identification number036948
Number of Individuals Covered346
Insurance policy start date2019-01-01
Insurance policy end date2019-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number36948
Policy instance 1
Insurance contract or identification number36948
Number of Individuals Covered332
Insurance policy start date2018-01-01
Insurance policy end date2018-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number36948
Policy instance 1
Insurance contract or identification number36948
Number of Individuals Covered324
Insurance policy start date2017-01-01
Insurance policy end date2017-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Are there contracts with allocated funds for individual policies?0
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number36948
Policy instance 1
Insurance contract or identification number36948
Number of Individuals Covered286
Insurance policy start date2015-01-01
Insurance policy end date2015-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Are there contracts with allocated funds for individual policies?No
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?Yes
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number36948-001
Policy instance 1
Insurance contract or identification number36948-001
Number of Individuals Covered303
Insurance policy start date2014-01-01
Insurance policy end date2014-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Are there contracts with allocated funds for individual policies?No
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?No
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number36948-001
Policy instance 1
Insurance contract or identification number36948-001
Number of Individuals Covered271
Insurance policy start date2013-01-01
Insurance policy end date2013-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Are there contracts with allocated funds for individual policies?No
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?No
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number36948-001
Policy instance 1
Insurance contract or identification number36948-001
Number of Individuals Covered273
Insurance policy start date2012-01-01
Insurance policy end date2012-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $0
Are there contracts with allocated funds for individual policies?No
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?No
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number36948-001
Policy instance 1
Insurance contract or identification number36948-001
Number of Individuals Covered271
Insurance policy start date2011-01-01
Insurance policy end date2011-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $4,231
Are there contracts with allocated funds for individual policies?No
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?No
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
PRUDENTIAL RETIREMENT INSURANCE AND ANNUITY COMPANY (National Association of Insurance Commissioners NAIC id number: 93629 )
Policy contract number36948-001
Policy instance 1
Insurance contract or identification number36948-001
Number of Individuals Covered276
Insurance policy start date2010-01-01
Insurance policy end date2010-12-31
Total amount of commissions paid to insurance brokerUSD $0
Total amount of fees paid to insurance companyUSD $14,701
Are there contracts with allocated funds for individual policies?No
Are there contracts with allocated funds for group deferred annuity?No
Are there contracts with allocated funds for types other than group deferred annuity or individual?No
Contract purchased, in whole or in part, to distribute benefits from a terminating planNo
Contracts With Unallocated Funds Deposit Administration0
Are there contracts with unallocated funds for contracts of type immediate participation guarantee?No
Are there contracts with unallocated funds for contracts of type guaranteed investment?No
Are there contracts with unallocated funds for contract types other than deposit administration, immediate participation guarantee or guaranteed investment?No
Health Insurance Welfare BenefitNo
Dental Insurance Welfare BenefitNo
Vision Insurance Welfare BenefitNo
Life Insurance Welfare BenefitNo
Temporary Disability Insurance Welfare BenefitNo
Long Term Disability Insurance Welfare BenefitNo
Unemployment Insurance Welfare BenefitNo
Were dividends or retroactive rate refunds paid in cash?No
Were dividends or retroactive rate refunds paid as a credit?No
Did the insurance company fail to provide any information necessary to complete Schedule A of form 5500?No
Amount paid for insurance broker fees14701
Additional information about fees paid to insurance brokerSERVICES TO INSURER OR PLAN
Insurance broker organization code?4
Insurance broker nameNRP FINANCIAL, INC.

Potentially related plans

Was this data useful?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer
The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Copyright © Market Footprint Ltd
Contact us   Datalog Company Directory
401k Lookup     VAT Lookup S3